Savaria Corp (SISXF) reports robust Q4 results with significant gains in patient care, while navigating tariff uncertainties ...

Investment analysts at Desjardins issued their Q1 2025 EPS estimates for shares of Savaria in a report issued on Thursday, March 6th. Desjardins analyst F. Tremblay anticipates that the company will ...

Real-time index price for TSX Cannabis Index (XCAN), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

In a report released today, Frederic Tremblay from Desjardins maintained a Buy rating on Savaria (SIS – Research Report), with a price target ...

Full Year 2024 Results Key Financial Results Revenue: CA$867.8m (up 3.7% from FY 2023). Net ...

TD Securities lowered the firm’s price target on Savaria (SISXF) to C$22 from C$25 and keeps a Buy rating on the shares.Discover the Best ...

Equities research analysts at Raymond James issued their Q1 2025 earnings per share (EPS) estimates for shares of Savaria in a report issued on Thursday, March 6th. Raymond James analyst M. Glen ...

This dividend stock is ideal for those looking to gain some passive income that lasts – and in an industry that won't ...

This dividend stock looks like a major winner for TFSA investors, so if you only have $50 to spend on a regular basis, put it ...

“Our record-breaking year finished with an adjusted EBITDA of $161.2M, a 24% improvement over 2023, largely attributable to our Savaria One program that successfully achieved cost improvements ...

My name is Sarah, and I will be your conference operator today. At this time, I would like to welcome everyone to Savaria Corporation's Q4 2024 Conference Call. [Operator Instructions].

Words from the Executive Chairman and from the President & CEO "Our record-breaking year finished with an adjusted EBITDA of $161.2M, a 24% improvement over 2023, largely attributable to our Savaria ...